Revisions for Safety evaluation of Recombinant Human Erythropoietin ior EPOCIM in the treatment of patient with cerebral infarction acute. Study Stage I. | Registro Público Cubano de Ensayos Clínicos

The revisions let you track differences between multiple versions of a post.

To edit, publish or delete one of the revisions below, click on its saved date.

Published clinical_trials Safety evaluation of Recombinant Human Erythropoietin ior EPOCIM in the treatment of patient with cerebral infarction acute. Study Stage I. has 2 revisions.

Revision		Status
Saved 01/06/2017 - 2:11pm by CIMAB		in draft/pending publication
Saved 01/06/2017 - 2:11pm by CIMAB		current revision (published)

Registered Trials

Registration process

About the RPCEC

Useful resources